Acamprosate Calcium (AvKARE, Inc.)
Welcome to the PulseAid listing for the Acamprosate Calcium drug offered from AvKARE, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
| NON-PROPRIETARY NAME: | Acamprosate Calcium |
| SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-05-16 |
| END MARKETING DATE: | 0000-00-00 |
Acamprosate Calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acamprosate Calcium from AvKARE, Inc. |
| LABELER NAME: | AvKARE, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 333(mg/1) |
| START MARKETING DATE: | 2016-05-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42291-104_1f989f72-744b-dd1b-a8b2-8f7562d5b150 |
| PRODUCT NDC: | 42291-104 |
| APPLICATION NUMBER: | ANDA200143 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers:
